Argatroban dosing in obesity

Elagizi, S; Davis, K

Elagizi, S (reprint author), Ochsner Med Ctr, Dept Pharm, 1514 East Jefferson Hwy, New Orleans, LA 70121 USA.

THROMBOSIS RESEARCH, 2018; 163 (): 60

Abstract

Purpose: Obesity is associated with significant alterations in pharmacokinetic and pharmacodynamic properties. The use of weight based anticoagulants ......

Full Text Link